84 related articles for article (PubMed ID: 17026791)
41. Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa.
Piazzi G; Paterini P; Ceccarelli C; Pantaleo MA; Biasco G
Br J Cancer; 2006 Dec; 95(11):1525-8. PubMed ID: 17088913
[TBL] [Abstract][Full Text] [Related]
42. Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma.
McIntyre JB; Bose P; Klimowicz AC; Brockton NT; Petrillo S; Matthews W; Easaw J; Magliocco A; Dort JC
PLoS One; 2012; 7(2):e31723. PubMed ID: 22359620
[TBL] [Abstract][Full Text] [Related]
43. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
Manda SV; Kataria Y; Tatireddy BR; Ramakrishnan B; Ratnam BG; Lath R; Ranjan A; Ray A
J Neurosurg; 2018 Apr; 128(4):1091-1101. PubMed ID: 28574310
[TBL] [Abstract][Full Text] [Related]
44. Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma.
Tykocinski ES; Grant RA; Kapoor GS; Krejza J; Bohman LE; Gocke TA; Chawla S; Halpern CH; Lopinto J; Melhem ER; O'Rourke DM
Neuro Oncol; 2012 May; 14(5):613-23. PubMed ID: 22492960
[TBL] [Abstract][Full Text] [Related]
45. Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas.
Biernat W; Huang H; Yokoo H; Kleihues P; Ohgaki H
Brain Pathol; 2004 Apr; 14(2):131-6. PubMed ID: 15193025
[TBL] [Abstract][Full Text] [Related]
46. Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics.
Jeuken J; Sijben A; Alenda C; Rijntjes J; Dekkers M; Boots-Sprenger S; McLendon R; Wesseling P
Brain Pathol; 2009 Oct; 19(4):661-71. PubMed ID: 19744038
[TBL] [Abstract][Full Text] [Related]
47. Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype.
Damstrup L; Wandahl Pedersen M; Bastholm L; Elling F; Skovgaard Poulsen H
Int J Cancer; 2002 Jan; 97(1):7-14. PubMed ID: 11774237
[TBL] [Abstract][Full Text] [Related]
48. Structural insights into the role and targeting of EGFRvIII.
Bagchi A; Stayrook SE; Xenaki KT; Starbird CA; Doulkeridou S; El Khoulati R; Roovers RC; Schmitz KR; van Bergen En Henegouwen PMP; Ferguson KM
Structure; 2024 Jun; ():. PubMed ID: 38908376
[TBL] [Abstract][Full Text] [Related]
49. Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.
Li G; Mitra SS; Monje M; Henrich KN; Bangs CD; Nitta RT; Wong AJ
J Neurooncol; 2012 Jul; 108(3):395-402. PubMed ID: 22382786
[TBL] [Abstract][Full Text] [Related]
50. EGFR soluble isoforms and their transcripts are expressed in meningiomas.
Guillaudeau A; Durand K; Bessette B; Chaunavel A; Pommepuy I; Projetti F; Robert S; Caire F; Rabinovitch-Chable H; Labrousse F
PLoS One; 2012; 7(5):e37204. PubMed ID: 22623992
[TBL] [Abstract][Full Text] [Related]
51. EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers.
Faulkner C; Palmer A; Williams H; Wragg C; Haynes HR; White P; DeSouza RM; Williams M; Hopkins K; Kurian KM
Br J Neurosurg; 2015 Feb; 29(1):23-29. PubMed ID: 25141189
[TBL] [Abstract][Full Text] [Related]
52. Intragenic
Zheng L; Luthra R; Alvarez HA; San Lucas FA; Duose DY; Wistuba II; Fuller GN; Ballester LY; Roy-Chowdhuri S; Sweeney KJ; Rashid A; Yang RK; Chen W; Liu A; Wu Y; Albarracin C; Patel KP; Routbort MJ; Sahin AA; Ding Q; Chen H
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201434
[TBL] [Abstract][Full Text] [Related]
53. Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer.
Khelwatty SA; Essapen S; Bagwan I; Green M; Seddon AM; Modjtahedi H
Oncotarget; 2019 Mar; 10(18):1704-1715. PubMed ID: 30899442
[TBL] [Abstract][Full Text] [Related]
54. The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy.
Pedersen MW; Meltorn M; Damstrup L; Poulsen HS
Ann Oncol; 2001 Jun; 12(6):745-60. PubMed ID: 11484948
[TBL] [Abstract][Full Text] [Related]
55. Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme.
Lin Y; Zhou J; Xu J; Zhao K; Liu X; Wang G; Zhang Z; Ge Y; Zong Y; Xu D; Tan Y; Fang C; Kang C
Oncol Lett; 2018 Apr; 15(4):5751-5759. PubMed ID: 29563997
[TBL] [Abstract][Full Text] [Related]
56. A U87-EGFRvIII cell-specific aptamer mediates small interfering RNA delivery.
Zhang X; Liang H; Tan Y; Wu X; Li S; Shi Y
Biomed Rep; 2014 Jul; 2(4):495-499. PubMed ID: 24944794
[TBL] [Abstract][Full Text] [Related]
57. Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities.
Struve N; Hoffer K; Weik AS; Riepen B; Krug L; Cetin MH; Burmester J; Ott L; Liebing J; Gatzemeier F; Müller-Goebel J; Gerbach M; Bußmann L; Parplys AC; Unger K; Mansour WY; Schüller U; Rieckmann T; Petersen C; Rothkamm K; Short SC; Kriegs M
Neurooncol Adv; 2022; 4(1):vdab180. PubMed ID: 35274102
[TBL] [Abstract][Full Text] [Related]
58. Low Incidence along with Low mRNA Levels of
Peciak J; Stec WJ; Treda C; Ksiazkiewicz M; Janik K; Popeda M; Smolarz M; Rosiak K; Hulas-Bigoszewska K; Och W; Rieske P; Stoczynska-Fidelus E
J Cancer; 2017; 8(1):146-151. PubMed ID: 28123609
[No Abstract] [Full Text] [Related]
59. Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention.
Pabla B; Bissonnette M; Konda VJ
World J Clin Oncol; 2015 Oct; 6(5):133-41. PubMed ID: 26468449
[TBL] [Abstract][Full Text] [Related]
60. EGFR
Rutkowska A; Stoczyńska-Fidelus E; Janik K; Włodarczyk A; Rieske P
J Oncol; 2019; 2019():1092587. PubMed ID: 32089685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
